InvestorsHub Logo
Followers 2
Posts 239
Boards Moderated 0
Alias Born 03/23/2007

Re: None

Friday, 10/16/2020 4:32:29 PM

Friday, October 16, 2020 4:32:29 PM

Post# of 144820
Invetech to develop GMP-compliant encapsulation by end 2022

TreeFrog Therapeutics and Invetech Expand Partnership to Transition High-throughput Stem Cell Encapsulation Technology to GMP System for Commercial-scale Cell Therapy Manufacturing
October 7, 2020 By Cade Hildreth

* TreeFrog Therapeutics and Invetech started their collaboration in 2019 to industrialize TreeFrog’s stem cell encapsulation technology to enable the mass production of hPSC-derived cell therapies in industrial bioreactors, with best-in-class cell quality and low production costs.

* Invetech delivered a beta encapsulation system with a throughput of 1,000 stem cell capsules per second to TreeFrog Therapeutics in the second quarter of 2020.

* The strategic partnership aims to develop a GMP-compliant encapsulation device by the end of 2022 to support TreeFrog Therapeutics’ in-house and partnered cell therapy programs.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMCB News